Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
8,818,353
-
Share change
-
+94,179
-
Total reported value
-
$255,615,973
-
Price per share
-
$28.97
-
Number of holders
-
126
-
Value change
-
+$2,934,173
-
Number of buys
-
46
-
Number of sells
-
55
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2025
As of 31 Dec 2025,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,818,353 shares.
The largest 10 holders included
BNP PARIBAS FINANCIAL MARKETS, GOLDMAN SACHS GROUP INC, UBS Group AG, Kingsview Wealth Management, LLC, Midwest Financial Partners Investments, Inc., NTV Asset Management LLC, Canal Insurance CO, SG Americas Securities, LLC, HighTower Advisors, LLC, and Cambridge Investment Research Advisors, Inc..
This page lists
126
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.